Top of this page
Skip navigation, go straight to the content

Products

UCB Group's medicines are making a real difference to the lives of people all over the world. Some of our products are among the leaders in their field.

Our main products

  • Keppra®

    Keppra® (levetiracetam) is indicated for the treatment of several types of epilepsy including add-on treatment for adults and children from 4 years of age with partial onset seizures.
  • Nootropil®

    Nootropil® (piracetam) is a cerebral function regulator, used to treat adults and the elderly.
  • Xyzal®

    Xyzal® (levocetirizine) is an antihistamine for the symptomatic treatment of allergic rhinitis, including persistent allergic rhinitis, and chronic idiopathic urticaria.
  • Zyrtec®

    Zyrtec® (cetirizine) is an antihistamine treatment for the symptoms of perennial allergic rhinitis, seasonal allergic rhinitis and chronic idiopathic urticaria.
  • Deponit®

    Deponit® (glyceryl trinitrate) is indicated in the treatment of coronary heart disease in adults and elderly.
  • Tussionex™

    Tussionex™ (hydrocodone polistirex and chlorpheniramine polistirex) (CIII) is used for relief of cough and upper respiratory symptoms associated with allergy or cold in adults and children 6 years of age and older.
  • Metadate-CD™

    Metadate-CD™ / Equasym™ (methylphenidate HCl) (CII) is used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children over 6 years of age.
  • Neupro®

    Neupro® (rotigotine) is a transdermal patch used in the treatment of Parkinson's Disease in adults and elderly.
  • Univasc™/Femipres™/Perdix™

    Univasc™/Femipres™/Perdix™ is indicated for the treatment of essential hypertension in adults and elderly.
  • Edex®/Viridal®

    Edex®/Viridal® is indicated in erectile dysfunction in adults and elderly.
  • Isoket®

    Isoket® (isosorbide dinitrate) is used for the treatment of angina and heart failure in adults and elderly.

Please note

The medicinal products mentioned here are not approved for sale on all markets worldwide.

Moreover, currently registered indications of said products may differ from country to country.

Therefore, physicians should always consult local prescribing information.

Patients should always consult their physician for information regarding these medicinal products.